183 Quantitative Perfusion CMR in ANOCA 26. Utz W, Niendorf T, Wassmuth R, Messroghli D, Dietz R, Schulz-Menger J. Contrastdose relation in first-pass myocardial MR perfusion imaging. J Magn Reson Imaging. 2007;25(6):1131-5. 27. Sharrack N, Chiribiri A, Schwitter J, Plein S. How to do quantitative myocardial perfusion cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. 2022;23(3):315-8. 28. Ta AD, Hsu LY, Conn HM, Winkler S, Greve AM, Shanbhag SM, et al. Fully quantitative pixel-wise analysis of cardiovascular magnetic resonance perfusion improves discrimination of dark rim artifact from perfusion defects associated with epicardial coronary stenosis. J Cardiovasc Magn Reson. 2018;20(1):16. 29. Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res. 2001;50(1):151-61. 30. Chamuleau SA, Siebes M, Meuwissen M, Koch KT, Spaan JA, Piek JJ. Association between coronary lesion severity and distal microvascular resistance in patients with coronary artery disease. Am J Physiol Heart Circ Physiol. 2003;285(5):H2194-200. 31. Hillier E, Elharram M, White JA, Anderson T, Luu J, Labib D, et al. Heterogeneity of Coronary Vascular Function and Myocardial Oxygenation in Women with Angina and Non-obstructive Coronary Artery Disease. Eur Heart J Cardiovasc Imaging. 2024. 32. Thomson LE, Wei J, Agarwal M, HaftBaradaran A, Shufelt C, Mehta PK, et al. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women’s Ischemia Syndrome Evaluation. Circ Cardiovasc Imaging. 2015;8(4). 33. Kotecha T, Chacko L, Chehab O, O’Reilly N, Martinez-Naharro A, Lazari J, et al. Assessment of Multivessel Coronary Artery Disease Using Cardiovascular Magnetic Resonance Pixelwise Quantitative Perfusion Mapping. JACC Cardiovasc Imaging. 2020;13(12):2546-57. 34. Zhou W, Lee JCY, Leung ST, Lai A, Lee TF, Chiang JB, et al. Long-Term Prognosis of Patients With Coronary Microvascular Disease Using Stress Perfusion Cardiac Magnetic Resonance. JACC Cardiovasc Imaging. 2021;14(3):602-11. 35. Knott KD, Seraphim A, Augusto JB, Xue H, Chacko L, Aung N, et al. The Prognostic Significance of Quantitative Myocardial Perfusion: An Artificial Intelligence-Based Approach Using Perfusion Mapping. Circulation. 2020;141(16):1282-91. 36. Zhao W, Li K, Tang L, Zhang J, Guo H, Zhou X, et al. Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis in Patients With Type 2 Diabetes Using Quantitative Perfusion MRI. J Magn Reson Imaging. 2024. 37. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21-9. 38. Zhou W, Sin J, Yan AT, Wang H, Lu J, Li Y, et al. Qualitative and Quantitative Stress Perfusion Cardiac Magnetic Resonance in Clinical Practice: A Comprehensive Review. Diagnostics (Basel). 2023;13(3). 8
RkJQdWJsaXNoZXIy MTk4NDMw